UNSPSC 85893838: High dose rate (hdr) brachytherapy of prostate using cesium 137 (cs-137)

This classification denotes the group of activities that yields a radiation therapy intervention or procedure of high dose rate (hdr) brachytherapy of prostate using cesium 137 (cs-137). This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code DV1097Z

UNSPSC 85893838 High dose rate (hdr) brachytherapy of prostate using cesium 137 (cs-137) is a Commodity code with a significant mismatch between its nominal scope and recent state and local procurement activity. The code's technical specification — a specialized cancer treatment modality — does not align with the documented recent opportunity, which solicits temporary health professional staffing services across ancillary clinical categories including audiology, cardiology, diagnostic imaging, gastroenterology, orthopedics, respiratory care, sterile processing, surgical services, and therapy. State and local buyers have posted no recent opportunities specifically for brachytherapy equipment, treatment delivery, or related oncology services under this code.

The County of Santa Clara Health System posted the sole recent opportunity on July 7, 2026, as a non-exclusive, multiple-award qualification vehicle (RFSQHHSFY270052) with proposals due October 7, 2026. The solicitation establishes a qualified vendor pool for temporary staffing to meet operational needs over a potential five-year term, with no guaranteed volume or contract awards. Proposers may bid for all or specific health professional categories without penalty for single-specialty focus, and qualifications will be negotiated case by case. The mismatch between the code's brachytherapy specification and Santa Clara's staffing focus suggests the code shows little relevant recent activity in state and local procurement, or that the opportunity was mislabeled in the source system.